Company
United StatesPublic company, NASDAQ: ANABAnaptysBio (NASDAQ: ANAB), San Diego, CA – FDA Inspections
Inspection records and compliance data for AnaptysBio in San Diego, CA. 1 FDA inspection on record, 1 Form 483, last inspected April 29, 2026. Publicly traded as NASDAQ: ANAB.
Company Profile
This profile covers AnaptysBio based in San Diego, CA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected April 29, 2026.
Most cited issue areas
- General responsibilities of sponsors1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 29, 2026 | Not classified | Human Drugs · Bioresearch Monitoring | 1315526 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
AnaptysBio
Stock ticker
ANAB
Exchange
NASDAQ
Share price
$47.77
Market cap
$1.4B
Price as of
November 13, 2026
FEI Number
3020705743
Address
10770 Wateridge Cir Ste 210, San Diego, CA 92121-5801, United States
Country
United States
ID: 719b8042-9b20-4c2a-b273-49dc6524b06b